Current studies have demonstrated that high expression of KIAA1429 facilitates migration and invasion of hepatocellular carcinoma and is associated with poor prognosis among hepatocellular carcinoma patients (Cheng et al., 2019; Lan et al., 2019). Here, VIRMA is linked to hepatocellular carcinoma.